M34.2
BillableSystemic sclerosis induced by drug and chemical
HCC Category Mapping
V24HCC 40 — Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.307ESRDHCC 40 — Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.000RxHCCHCC 82 — Systemic Sclerosis (Scleroderma)
0.000What This Code Means
Systemic sclerosis-like symptoms that develop as a side effect from exposure to certain medications or chemicals.
Coding Tips
- •Always document the specific drug or chemical causing the condition in the medical record
- •Use an external cause code to identify the triggering substance when applicable
Clinical Significance
Drug-induced systemic sclerosis represents a potentially reversible form when the causative agent is identified and discontinued. This diagnosis is crucial for preventing continued exposure and managing the inflammatory process while monitoring for resolution.
Documentation Requirements
- ✓Documentation of systemic sclerosis-like symptoms
- ✓Identification of specific drug or chemical causing the condition
- ✓Timeline showing relationship between exposure and symptom onset
- ✓Exclusion of idiopathic systemic sclerosis
- ✓Documentation of improvement after agent discontinuation
- ✓Laboratory studies supporting scleroderma-like syndrome
- ✓Treatment plan including avoidance of causative agent
- ✓Monitoring plan for resolution or progression